Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
posted on
Jul 08, 2019 04:27PM
Two big positives about Sept DL:
- all the investment community will be back to work
- it gives them a good amount of time to get those adjudicated events in,... i assume that adds to the total patient years as well.